Open AccessOvercoming acquired chemo-resistance to gemcitabine: implications from the perspective of multi-modal therapy including surgery for pancreatic cancer
Author(s) -
Fuyuhiko Motoi
Publication year - 2021
Language(s) - English
DOI - 10.20517/cdr.2021.75
Subject(s) - gemcitabine , medicine , pancreatic cancer , chemotherapy , pancreatic ductal adenocarcinoma , oncology , disease , drug resistance , intensive care medicine , cancer , biology , microbiology and biotechnology